| Hans-Günter Meyer-Thompson | Buprenorphin
Depot buprenorphine: Safe and effective for clients in jails and prisons?
Depot buprenorphine: Safe and effective for clients in jails and prisons?
There are barriers to receiving opioid use disorder medications, such as buprenorphine, for individuals in criminal justice settings like jails and prisons. These include limited resources to ensure adequate medical monitoring and the potential for their illegal sharing or selling (i.e., diversion) to other inmates. This study examined safety and opioid use outcomes in a group of incarcerated individuals who received a longer acting, injection formulation of buprenorphine. (Recovery Research Institute, USA, Juli 2022)
https://www.recoveryanswers.org/research-post/depot-buprenorphine-safe-effective-clients-jails-prisons/